Edit
Minerva Neurosciences
http://www.minervaneurosciences.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabLast activity: 10.03.2024
Dedicated to transforming the lives of patients with central nervous system diseases through innovative solutions.
Location: United States, Massachusetts, Waltham
Employees: 11-50
Founded date: 2007
Investors 1
| Date | Name | Website |
| - | Vivo Capit... | vivocapita... |
Mentions in press and media 12
| Date | Title | Description | Source |
| 10.03.2024 | Blockbuster BeiGene Cancer Drug Adds Another FDA Approval | A BeiGene drug already used to treat several types of blood cancer now has an additional FDA approva... | medcitynew... |
| 09.08.2022 | Minerva Neurosciences Reports Second Quarter 2022 Financial ... | WALTHAM, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clin... | globenewsw... |
| 04.05.2022 | Minerva Neurosciences Reports First Quarter 2022 Financial R... | WALTHAM, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clini... | globenewsw... |
| 28.02.2022 | Minerva Neurosciences Announces Publication of Roluperidone ... | WALTHAM, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clin... | globenewsw... |
| 05.01.2022 | Minerva Neurosciences : Corporate Presentation at LifeSci Pa... | Corporate Presentation January 2022 Forward-Looking Statement Safe-Harbor Forward-Looking Safe Harbo... | marketscre... |
| 08.11.2021 | Minerva Neurosciences Reports Third Quarter 2021 Financial R... | Company to Host Conference Call Today at 8:30 a.m. ET WALTHAM, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE)... | globenewsw... |
| 08.11.2021 | Minerva Neurosciences Reports Third Quarter 2021 Financial R... | Company to Host Conference Call Today at 8:30 a.m. ET WALTHAM, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE)... | marketscre... |
| 01.11.2021 | Minerva Neurosciences to Report Third Quarter 2021 Financial... | WALTHAM, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clin... | globenewsw... |
| 11.10.2021 | Minerva Neurosciences Announces Promotion of Geoff Race to P... | Frederick Ahlholm is Named Chief Financial Officer as Company Prepares to Submit a Pre-NDA Meeting R... | globenewsw... |
| 12.02.2021 | Astellas, Seagen pave the way for Padcev's global rollou... | To put it mildly, regulators at the FDA have a few problems with Minerva’s $NERV failed schizophreni... | endpts.com... |
Show more